Poof—your FUD narrative just evaporated. Vivos' SEC filings and PRs clearly state they are actively engaged with both Indian and US officials. I don't know why you're continuing to lie when the facts are so clear.
You keep using the word “shut down” as if it were an enforcement action. It wasn’t.
There was an initial academic phase. There is now a regulatory review phase with DCGI for continuation and expansion.
That’s not a “shutdown.” That’s how clinical programs transition between stages.
You also keep claiming there are “no pending applications.” The company publicly stated in its Feb 3 update that DCGI clearance is anticipated this quarter and that an IDE submission update is forthcoming.
If there were no pending regulatory interaction, they wouldn’t be referencing ongoing review.
Repeating “no trials anywhere” while the company is in active regulatory review is like saying “there’s no flight” while the plane is at the gate awaiting clearance.
You’re just a serial liar and troll whose only agenda is to spread BS.
Pity the fool who listens to your habitual lies and fabrications.
Market Data 
Markets 
AI
